---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-259994"
form_type: "8-K"
ticker: "SNSE"
cik: "0001829802"
company_name: "Sensei Biotherapeutics, Inc."
filed_at: "2023-10-20T23:59:59+00:00"
generated_at: "2026-06-09T18:54:51.389663+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sensei Biotherapeutics receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Nasdaq notified Sensei on Oct 17, 2023 that stock bid price <$1 for 30 consecutive days, violating Listing Rule 5450(a)(1).
- Company has 180 days (until April 15, 2024) to regain compliance by closing at $1.00+ for 10 consecutive business days.
- Options include transferring to Nasdaq Capital Market or effecting a reverse stock split; company will monitor and consider remedies.
- If not cured within compliance periods, Nasdaq will delist shares; company may appeal to a Hearings Panel.

## SEC filing metadata
- accession: 0001193125-23-259994
- form_type: 8-K
- ticker: SNSE
- cik: 0001829802
- company_name: Sensei Biotherapeutics, Inc.
- filed_at: 2023-10-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829802/000119312523259994/0001193125-23-259994-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829802/000119312523259994/d560954d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-259994
- JSON: https://secwatch.observer/filing/0001193125-23-259994.json
- Plain text: https://secwatch.observer/filing/0001193125-23-259994.txt

## Key facts
- Listing & Compliance Notices
  Sensei Biotherapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: October 17, 2023, Sensei Biotherapeutics, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Market, as the minimum bid price of the Company’s common stock was less than $1.00 per share for the previous 30 consecutive business days. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days, or until April 15, 2024, to regain compliance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829802/000119312523259994/0001193125-23-259994-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.